Article info
Inflammatory bowel disease
Original research
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies
- Correspondence to Dr Atsushi Sakuraba, Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL 60637, USA; asakurab{at}medicine.bsd.uchicago.edu
Citation
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies
Publication history
- Received May 5, 2020
- Revised November 24, 2020
- Accepted November 25, 2020
- First published December 17, 2020.
Online issue publication
October 07, 2021
Article Versions
- Previous version (17 December 2020).
- Previous version (21 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.